Upper band
0
Emcure Pharmaceuticals has received a good response to its IPO, with shares trading at a premium of Rs 360 in the unlisted market. Based on the upper price ...
Emcure Pharmaceuticals has received a good response to its IPO, with shares trading at a premium of Rs 360 in the unlisted market. Based on the upper price ...